Investing.com -- Exelixis, Inc. (NASDAQ: EXEL) shares plunged 10.2% after the biopharmaceutical company reported second-quarter revenue that fell short of analyst expectations.

"TIPS provides a trusted and efficient pathway for government clients to access advanced screening technologies," said Dolan Falconer, Chief Executive Officer of ScanTech AI. "Through our partnership ...

GATX invested over $515 million year-to-date and continues to pursue its previously announced joint venture with Brookfield Infrastructure (NYSE: BIPC) to acquire Wells Fargo (NYSE: WFC )’s rail ...

Investing.com -- Amazon (NASDAQ: AMZN) could be a major beneficiary of the recently signed One Big Beautiful Bill Act (OBBBA), with Morgan Stanley (NYSE: MS) estimating the company may capture around ...

Investing.com -- Coastal Financial Corporation (NASDAQ: CCB) saw its shares fall 4.3% Tuesday after reporting second quarter earnings that fell short of analyst expectations, as both revenue and ...

Investing.com -- Atossa Therapeutics Inc (NASDAQ: ATOS) stock surged 11.4% premarket following positive feedback from the U.S. Food and Drug Administration (FDA) regarding the company’s proposed dose ...

The biopharmaceutical company disclosed that the Nasdaq Hearings Panel has granted it additional time to meet the exchange’s listing standards. Salarius now has until mid-August 2025 to comply with ...

Investing.com -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) stock surged 32.9% premarket following the publication of a peer-reviewed article validating the disease-modifying potential of its ...

Investing.com -- JP Morgan downgraded Cellnex to Neutral from Overweight, warning that upcoming tower sales may raise less ...

The acquisition includes Durect’s novel therapeutic molecule, larsucosterol, which has shown promising results in Phase 2 trials for treating alcoholic hepatitis (AH). Under the terms of the agreement ...

According to Barclays, Apple’s “longer-term AI strategy remains muddy,” especially when compared with other major tech players. The firm noted Apple’s “asset-light approach to AI… relying on the ...

In Europe, UBS sees value in “quality stocks—those with high profitability, stable earnings, and robust balance sheets.” The ...